Official COVID-19 Hotline in the Philippines
Statement Against Use of Chloroquine or Hydroxchloroquine
What to do during a Code Red Alert Level 4, Sub-level 1
PCP and ÂÖÅÌ¶Ä invites you to a free Webinar on #COVID19
ÂÖÅÌ¶Ä Triage Algorithm in Management of COVID-19
Most Asked Questions on COVID-19 Answered by ÂÖÅÌ¶Ä Experts!
Dr. Jemelyn Garcia, FPCP, FÂÖÅ̶Ä
Dr. Maria Sonia Salamat, FPCP, FÂÖÅ̶Ä
Dr. Marja B. Buensalido, FPCP, FÂÖÅ̶Ä
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FÂÖÅ̶Ä
Dr. Yvette Silubrico, FPCP, FÂÖÅ̶Ä
Dr. Chatie Olasiman, FPCP, FÂÖÅ̶Ä
Dr. Ma. Charmian Hufano, FPCP, FÂÖÅ̶Ä
Dr. Mitzie Lou Osabel, FPCP, FÂÖÅ̶Ä
Dr. Janice C. Caoili, FPCP, FÂÖÅ̶Ä
The Philippine Society for Microbiology and Infectious Diseases (ÂÖÅ̶Ä) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.